Please Wait...

Marieke Cajal

Main profile

Marieke Cajal, PhD
Marieke Cajal, PhD
Research Development Director, Compass Research, Bioclinica Research Network

Dr. Marieke Cajal is the Research Development Director at Compass Research, part of Bioclinica Research Network, one of the leading research centers in Neurodegenerative Diseases.

Dr. Cajal began working as an academic researcher in 2008, and has since expanded her experience to all phases of clinical trials within numerous therapeutic areas.

Since joining Compass Research in 2015, she has successfully led patient recruitment in Central Nervous System trials employing a community outreach program to raise awareness of disease and clinical trials. She maintains strong relations with sponsors, physicians, healthcare organizations, and patient advocacy groups.

Dr. Cajal earned a doctorate in Neurosciences from Sorbonne Paris Cité while conducting research on brain development for the French National Centre for Scientific Research. Additionally she has a master’s in Genetics from Paris Diderot University and a bachelor’s from Evry University. Dr. Cajal is a member of The Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment (ISTAART).


Considering the large number of individuals affected by Alzheimer's disease (AD) or Mild Cognitive Impairment (MCI), you might expect fast enrollment into clinical trials. The reality is quite different. Sponsors of clinical trials face several obstacles: 1) Patients are underdiagnosed. 2) Patients have a limited knowledge of clinical trials and some misconceptions.


Leader in Clinical Trial
Management Solutions

Bioclinica is organized into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging & Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Molecular Marker Laboratory. Our eHealth segment comprises eClinical Solutions, Randomization & Trial Supply Management, Safety & Regulatory Solutions, and Financial Lifecycle Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.

What's next from Bioclinica? Hear if first during #PCTrials Europe next week in Amsterdam!
bioclinica (5 hours ago)
Join Bioclinica's Justin Hunt on Nov. 28 in a live webinar! Find out how to overcome common hurdles in CTMS impleme…
bioclinica (Yesterday)
Another CRO seeing big gains in the sites payments process! Access the Case Study here
bioclinica (Yesterday)
Great advice from our Dir. Cardiovascular Imaging on quality imaging acquisitions & assessments in clin trials.
bioclinica (Yesterday)
Almost here! #PCTrials Pre-arrange a meeting w @bioclinica Drop by & s/w David Kiger & Mike Lange. Mike will give a…
bioclinica (Yesterday)
Almost here! #PCTrials Pre-arrange a meeting w @bioclinica Drop by & s/w David Kiger & Mike Lange. Mike will giv…
bioclinica (Yesterday)

Latest Blogs:

Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen
Congressman Meehan and Bioclinica CEO John Hubbard at recent visit to Bioclinica's Audubon offices